相关实验视频

Updated: Apr 28, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

使用CNN-伯诺利随机森林模型预测微生物与药物之间的联系

Zihao Song¹, Qingnuo Li¹, Jincheng Zhao¹

¹The School of Computer Science and Artificial Intelligence & Aliyun School of Big Data, Changzhou University, Changzhou, China.

|August 11, 2025

概括

这项研究引入了一种新的计算模型,CNNBRFMDA,用于预测微生物与药物之间的关联,有助于发现新的抗生素治疗方法和打击抗菌素耐药性.

科学领域:

计算生物学是一种计算生物学.
生物信息学是一种生物信息学.
机器学习机器学习

背景情况:

抗生素耐药性是一个日益增长的全球健康威胁,需要新的治疗策略.
识别微生物与药物联系的传统方法耗时且昂贵.
计算模型为预测新型微生物与药物相互作用提供了一种有效的替代方案.

研究的目的:

开发和验证一种新的计算模型,用于预测微生物与药物之间的关联.
利用机器学习来有效识别潜在的抗微生物药物应用.
通过发现新的治疗途径,应对微生物耐药性的挑战.

主要方法:

开发了一个卷积神经网络与伯努利随机森林 (CNNBRFMDA) 模型.
使用已知的关联,微生物相似性和药物相似性来构建特征向量.
卷积神经网络减少了维度,伯努利随机森林进行了预测.

主要成果:

该CNNBRFMDA模型实现了高性能,在MDAD上平均AUC得分为0.9017,在生物膜数据集上为0.9146.
五次交叉验证证明了模型的稳定性和准确性.
案例研究证实了该模型的可靠性,高比例的顶级预测得到了文献审查的验证.

结论:

该CNNBRFMDA模型有效地预测了微生物与药物的关联,为药物发现提供了宝贵的工具.
这种计算方法提高了识别潜在抗菌疗法的效率和精度.
该模型有助于通过促进发现新型微生物与药物相互作用来打击抗菌素耐药性.

关键词:

协会预测协会预测伯努利的随机森林是一个随机森林.卷积神经网络是一种卷积神经网络.药物药物药物药物药物微生物的微生物是什么

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

相关概念视频

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...